Weiwei Ouyang
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- MicroRNA in disease regulation
Papers in
-
- Lung Cancer Diagnosis and Treatment 9
- Lung Cancer Treatments and Mutations 6
-
- RNA Interference and Gene Delivery 2
- Co-authors
- Lingyun Zhao (4 shared papers)Jintian Tang (5 shared papers)Shengfa Su (18 shared papers)Xing Zhao (5 shared papers)Bing Lü (10 shared papers)Zhu Ma (12 shared papers)Fuping Gao (3 shared papers)Xiaodong Zhang (2 shared papers)
- Journals
- BMC Cancer (4 papers)Frontiers in Oncology (3 papers)Journal of Clinical Oncology (3 papers)Radiation Oncology (2 papers)Journal of Inflammation Research (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Weiwei Ouyang
41 papers receiving 503 citations
Peers
Comparison fields: 5 of 77
- Biomaterials 99
- Cancer Research 54
- Pulmonary and Respiratory Medicine 94
- Oncology 76
- Immunology 54
Countries citing papers authored by Weiwei Ouyang
This map shows the geographic impact of Weiwei Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Ouyang more than expected).
Fields of papers citing papers by Weiwei Ouyang
This network shows the impact of papers produced by Weiwei Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Ouyang. The network helps show where Weiwei Ouyang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Ouyang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 87 | |
| 2 | 2023 | 76 | |
| 3 | 2013 | 52 | |
| 4 | 2017 | 43 | |
| 5 | 2015 | 35 | |
| 6 | 2024 | 26 | |
| 7 | 2014 | 19 | |
| 8 | 2013 | 17 | |
| 9 | 2014 | 15 | |
| 10 | 2021 | 13 | |
| 11 | 2023 | 13 | |
| 12 | 2022 | 13 | |
| 13 | 2014 | 12 | |
| 14 | 2023 | 10 | |
| 15 | 2024 | 7 | |
| 16 | 2017 | 7 | |
| 17 | 2014 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2020 | 5 |
About Weiwei Ouyang
Weiwei Ouyang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 512 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Viral gastroenteritis research and epidemiology (3 papers), Ultrasound and Hyperthermia Applications (3 papers), RNA Interference and Gene Delivery (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Biomaterials (99 citations), Cancer Research (54 citations), Pulmonary and Respiratory Medicine (94 citations), Oncology (76 citations) and Immunology (54 citations). Weiwei Ouyang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Lingyun Zhao, Jintian Tang, Shengfa Su, Xing Zhao, Bing Lü, Zhu Ma, Fuping Gao, Xiaodong Zhang, Xufei Wang and Yuhui Zhang. Their work appears in journals such as BMC Cancer, Frontiers in Oncology, Journal of Clinical Oncology, Radiation Oncology and Journal of Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.